New TB drug regimen controls resistant disease in 9 of 10 cases: study
New TB drug regimen controls resistant disease in 9 of 10 cases: study
(Reuters Health) - The new anti-tuberculosis drug combination of bedaquiline, pretomanid and linezolid cures 90% of people with deadly drug-resistant TB if given for six months, researchers report in The New England Journal of Medicine.
from Reuters: Health https://ift.tt/3algeMO
via Blogger https://ift.tt/2IkAcLF
March 05, 2020 at 06:40AM
(Reuters Health) - The new anti-tuberculosis drug combination of bedaquiline, pretomanid and linezolid cures 90% of people with deadly drug-resistant TB if given for six months, researchers report in The New England Journal of Medicine.
from Reuters: Health https://ift.tt/3algeMO
via Blogger https://ift.tt/2IkAcLF
March 05, 2020 at 06:40AM
No comments